Back to search
CIC-Rearranged Sarcoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which CIC-Rearranged Sarcoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which CIC-Rearranged Sarcoma trials you may qualify forThe study participant has been diagnosed with non-rhabdomyosarcoma (NRSTS). Primary Objectives Intermediate-Risk * To estimate the 3-year event-free survival…
The purpose of the study is to find out if pembrolizumab is a useful treatment that causes few or mild side effects in people with ultra-rare sarcoma. The resea…
This study is testing two different doses of BTX-A51 to determine if it is safe and tolerable in participants with liposarcoma with MDM2 amplification, myxoid l…
This phase II/III trial compares the effect of vincristine, irinotecan, and regorafenib (VIrR) in combination with vincristine, doxorubicin, cyclophosphamide (V…